⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL296540 | 0.79 | — | — | |
| SCHEMBL4647958 | 0.71 | — | — | |
| SCHEMBL296735 | 0.71 | — | — | |
| SCHEMBL7701955 | 0.67 | — | — | |
| SCHEMBL4645019 | 0.61 | — | — | |
| SCHEMBL1098508 | 0.61 | — | — | |
| SCHEMBL1098505 | 0.61 | — | — | |
| SCHEMBL31164821 | 0.59 | — | — | |
| SCHEMBL31259147 | 0.59 | — | — | |
| SCHEMBL323169 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4735160-A2 | FLOW CELLS WITH DENDRON ARCHITECTURE | Illumina, Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| WO-2025006346-A2 | FLOW CELLS WITH DENDRON ARCHITECTURE | ILLUMINA, INC. (US) | 2025-01-02 | — | — | WO | disclosed |
| WO-2023163227-A1 | ANTIBODY-DRUG CONJUGATE | ＵＢＥ株式会社 | 2023-08-31 | — | — | WO | disclosed |